BORRONI, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 21.217
EU - Europa 8.686
AS - Asia 4.294
AF - Africa 30
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 22
SA - Sud America 22
Totale 34.298
Nazione #
US - Stati Uniti d'America 21.176
CN - Cina 2.582
UA - Ucraina 2.374
DE - Germania 1.900
IT - Italia 1.057
HK - Hong Kong 927
PL - Polonia 802
GB - Regno Unito 649
FI - Finlandia 567
SG - Singapore 516
IE - Irlanda 423
FR - Francia 362
RU - Federazione Russa 246
IN - India 132
BE - Belgio 95
SE - Svezia 90
CZ - Repubblica Ceca 55
CA - Canada 34
TR - Turchia 34
VN - Vietnam 33
AU - Australia 26
NL - Olanda 26
EU - Europa 22
IR - Iran 18
MU - Mauritius 17
BR - Brasile 13
ES - Italia 12
KR - Corea 9
JP - Giappone 8
RO - Romania 6
TW - Taiwan 6
CL - Cile 5
MA - Marocco 4
MY - Malesia 4
SA - Arabia Saudita 4
TH - Thailandia 4
DK - Danimarca 3
EE - Estonia 3
KW - Kuwait 3
MX - Messico 3
TN - Tunisia 3
AL - Albania 2
AT - Austria 2
AZ - Azerbaigian 2
GR - Grecia 2
LV - Lettonia 2
MN - Mongolia 2
RS - Serbia 2
SL - Sierra Leone 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
AW - Aruba 1
BD - Bangladesh 1
BG - Bulgaria 1
BY - Bielorussia 1
BZ - Belize 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EG - Egitto 1
ID - Indonesia 1
IL - Israele 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 34.298
Città #
Fairfield 3.707
Woodbridge 2.816
Houston 1.875
Jacksonville 1.768
Ashburn 1.623
Seattle 1.438
Cambridge 1.344
Ann Arbor 1.321
Wilmington 1.236
Hong Kong 922
Warsaw 801
Princeton 786
Nanjing 639
Chandler 626
Dublin 423
New York 399
Beijing 329
Dearborn 325
Helsinki 314
Singapore 279
Nanchang 247
Brescia 218
Des Moines 175
Shenyang 174
San Diego 169
Changsha 152
Milan 150
Hebei 135
Jinan 119
Shanghai 119
Jiaxing 96
Tianjin 90
Brussels 88
Lancaster 87
Kunming 79
London 71
Boardman 63
Hangzhou 52
Ningbo 50
Norwalk 48
Los Angeles 47
San Mateo 45
Verona 45
Nürnberg 42
Zhengzhou 41
Munich 36
Romola 36
Taizhou 36
San Francisco 35
Augusta 30
Dong Ket 30
Guangzhou 30
Lanzhou 30
Olomouc 28
Brno 27
Toronto 26
Rome 25
Haikou 23
Leawood 22
Kilburn 21
Orange 20
Kocaeli 19
Fuzhou 18
Taiyuan 18
Hefei 16
Frankfurt am Main 15
Lappeenranta 15
Mumbai 15
Ardabil 13
Chiswick 13
Monmouth Junction 13
Torino 13
Changchun 12
Redwood City 12
Bologna 10
Hounslow 10
Naples 10
Padova 10
Pune 10
Washington 10
Catania 9
Chicago 9
Gunzenhausen 9
Prescot 8
San Jose 8
São Paulo 8
Trieste 8
Acton 7
Bergamo 7
Falkenstein 7
Melbourne 7
Phoenix 7
Sydney 7
Wandsworth 7
Cingia de' Botti 6
Lucca 6
Mantova 6
New Bedfont 6
Santa Clara 6
Taipei 6
Totale 26.424
Nome #
White matter changes in corticobasal degeneration syndrome and correlation with limb apraxia. 228
The Frontal Behavioural Inventory (Italian version) differentiates frontotemporal lobar degeneration variants from Alzheimer's disease. 213
Granulin mutation drives brain damage and reorganization from preclinical to symptomatic FTLD. 202
Mutation within TARDBP leads to Frontotemporal Dementia without motor neuron disease. 200
Evidence of white matter changes on diffusion tensor imaging in frontotemporal dementia. 200
[(11)C]-MP4A PET cholinergic measurements in amnestic mild cognitive impairment, probable Alzheimer's disease, and dementia with Lewy bodies: a Bayesian method and voxel-based analysis 195
Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators 184
CSF Alzheimer's disease-like pattern in Corticobasal Syndrome: evidence for a distinct disorder. 179
"Alien face" in corticobasal degeneration syndrome: Extending clinical features [2] 173
Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. 170
Discrimination of atypical parkinsonisms with transcranial magnetic stimulation 163
Is aceruloplasminemia treatable? Combining iron chelation and fresh-frozen plasma treatment 157
Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy 155
Altered brain metabolic connectivity at multiscale level in early Parkinson's disease 153
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains 153
Source-Based Morphometry Multivariate Approach to Analyze [123I]FP-CIT SPECT Imaging 152
Structural and functional imaging study in dementia with Lewy bodies and Parkinson's disease dementia. 151
QT dispersion and heart rate variability abnormalities in Alzheimer's disease and in mild cognitive impairment. 150
Action and object naming in frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration 149
Extrapyramidal symptoms in Frontotemporal Dementia: prevalence and clinical correlations 148
Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease. 145
Mendelian forms of disease and age at onset affect survival in frontotemporal dementia 145
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 143
Education plays a different role in Frontotemporal Dementia and Alzheimer's disease 142
Results from a pilot study on amiodarone administration in monogenic frontotemporal dementia with granulin mutation 142
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 142
COVID-19 impact on consecutive neurological patients admitted to the emergency department 142
Platelet amyloid precursor protein abnormalities in mild cognitive impairment predict conversion to dementia of Alzheimer type: a 2-year follow-up study. 141
Increased prevalence of silent myocardial ischaemia and severe ventricular arrhythmias in untreated patients with Alzheimer's disease and mild cognitive impairment without overt coronary artery disease 140
Functional correlates of Apolipoprotein E genotype in Frontotemporal Lobar Degeneration 139
A complicated case of intracranial hypotension: Diagnostic and management strategies 138
Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease 138
TARDBP mutations in frontotemporal lobar degeneration: frequency, clinical features, and disease course. 137
Is early-onset clinicallydifferent from late-onset frontotemporal dementia? 132
Do Beliefs about the Pathogenetic Role of Amyloid Affect the Interpretation of Amyloid PET in the Clinic. 132
Subcortical and deep cortical atrophy in Frontotemporal Lobar Degeneration. 131
EEG and granular osmiophilic elements in early-onset Alzheimer's disease. 127
The Speech and Language FOXP2 GeneModulates the Phenotype of Frontotemporal Lobar Degeneration 124
Cognitive and behavioral assessment in the early stages of neurodegenerative extrapyramidalsyndromes 124
Genetic bases of Progressive Supranuclear Palsy: the MAPT tau disease. 123
Two Sequential Tc-99m ECD SPECT Studies in a Case of Sporadic Creutzfeldt–Jakob Disease Confirmed at Autopsy 122
Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy 122
Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy 120
Metodo di generazione di un indice diagnostico per malattia di alzheimer, apparato elettronico di implementazione del metodo e sistema 120
Autoimmunity and frontotemporal dementia 119
A case report: doctor, my daughter has Alzheimer's disease. 118
Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD 118
Cortico-spinal tDCS in ALS: A randomized, double-blind, sham-controlled trial 118
A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease 117
Survival in frontotemporal lobar degeneration and related disorders: latent class predictors and brain functional correlates 117
The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is not significantly correlated to Transient Global Amnesia: preliminary results of an on-going study in Brescia Province, Italy. 117
Prefrontal cortex rTMS enhances action naming in Progressive Non-Fluent Aphasia 117
Advances on biological markers in early diagnosis of Alzheimer disease 117
Treatment of primary progressive aphasias by transcranial direct current stimulation combined with language training 116
Voluptuary Habits and Risk of Frontotemporal Dementia: A Case Control Retrospective Study 116
Serum leptin levels are higher in females affected by frontotemporal lobar degeneration than Alzheimer's disease 115
Atypical presentation of a novel Presenilin 1 R377W mutation: sporadic, late-onset Alzheimer disease with epilepsy and frontotemporal atrophy. 114
Early stage of behavioral variant frontotemporal dementia: clinical and neuroimaging correlates. 113
Response to comments on natural history and predictors of survival in progressive supranuclear palsy 113
Vascular risk factors and cognition in Parkinson's disease 113
A complicated case of intracranial hypotension: diagnostic and management strategies. 112
Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study 112
Action and object naming in Parkinson's disease without dementia. 111
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 111
VEGF gene and phenotype relation with Alzheimer's disease and mild cognitive impairment. 110
Association between tau H2 haplotype and age at onset in frontotemporal dementia 110
Sensitivity and specificity of transcranial magnetic stimulation for differential diagnosis of Alzheimer’s disease and frontotemporal dementia 110
A PCR-based protocol to accurately size C9orf72 intermediate-length alleles. 110
Iron in Frontotemporal Lobar Degeneration: A New Subcortical Pathological Pathway? 110
Phenotypic heterogeneity of Niemann-Pick disease type C in monozygotic twins. 109
Beyond cognitive reserve: behavioural reserve hypothesis in Frontotemporal Dementia. 109
Understanding Emotions in Frontotemporal Dementia: The Explicit and Implicit Emotional Cue Mismatch. 109
Behavioral dimensions and acetylcholinesterase inhibitor-related effect in Alzheimer disease over time: a latent trajectory modeling. 107
Choreo-athetosis in LRRK2 R1441C mutation: expanding the clinical phenotype. 107
Three sisters covering the transient global amnesia spectrum 106
Tau haplotype influences cerebral perfusion pattern in frontotemporal lobar degeneration and related disorders 106
A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies. 106
Anodal transcranial direct current stimulation of parietal cortex enhances action naming in Corticobasal Syndrome. 106
ADAM10 gene expression in the blood cells of Alzheimer's disease patients and mild cognitive impairment subjects. 106
Diagnosing Progressive Supranuclear Palsy: Role of Biological and Neuroimaging Markers 106
Serum C-Peptide, Visfatin, Resistin, and Ghrelin are Altered in Sporadic and GRN-Associated Frontotemporal Lobar Degeneration 106
Pattern ofbehavioral disturbances in corticobasal degeneration syndrome and progressivesupranuclear palsy 105
Preliminary Results on Long-Term Potentiation-Like Cortical Plasticity and Cholinergic Dysfunction After Miglustat Treatment in Niemann-Pick Disease Type C. 104
Early stages of probable Alzheimer disease are associated with changes in platelet amyloid precursor protein forms. 103
The Neuroimaging Signature of Frontotemporal Lobar Degeneration Associated with Granulin Mutations: An Effective Connectivity Study 103
Molecular signature of disease onset in granulin mutation carriers: a gene expression analysis study. 103
C9orf72 repeat expansions are restricted to the ALS-FTD spectrum. 103
White matter hyperintensities characterize monogenic frontotemporal dementia with granulin mutations. 103
Neuropsychiatric symptoms in amnestic and nonamnestic mild cognitive impairment. 102
APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk 102
Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia. 102
Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis. 102
Long term clinical and neurophysiological effects of cerebellar transcranial direct current stimulation in patients with neurodegenerative ataxia. 102
Common and rare TBK1 variants in early-onset Alzheimer disease in a European cohort. 102
Overlap between frontotemporal dementia and alzheimer's disease: Cerebrospinal fluid pattern and neuroimaging study 102
Cerebellar transcranial direct current stimulation in patients with ataxia: A double-blind, randomized, sham-controlled study. 101
Cerebrospinal fluid tau levels predict prognosis in non-inherited frontotemporal dementia. 101
Heterozygous TREM2 mutations in frontotemporal dementia 101
Brain magnetic resonance imaging structural changes in a pedigree of asymptomatic progranulin mutation carriers. 100
Functional and structural changes in Alzheimer’s disease and Mild Cognitive Impairment. Possible predictive role of QT Dispersion and Heart Rate Variability analisys 100
Totale 12.764
Categoria #
all - tutte 182.124
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 182.124


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208.324 0 0 0 1.341 715 1.237 1.091 1.193 829 1.071 309 538
2020/20216.319 181 845 254 695 343 680 245 720 784 617 698 257
2021/20223.171 213 539 69 148 29 162 228 236 190 416 280 661
2022/20232.442 448 115 63 152 155 675 24 171 273 71 171 124
2023/20243.243 169 72 289 209 107 499 111 117 950 65 58 597
2024/2025248 79 50 88 31 0 0 0 0 0 0 0 0
Totale 35.004